Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine and arginine rich splicing factor 8C, pseudogene (SRSF8CP) is a genomic DNA sequence similar to the functional SRSF8 gene, but lacks coding potential and is not known to produce a functional protein. Pseudogenes such as SRSF8CP are typically classified as “processed” or “unprocessed,” depending on their genomic structure, and are considered evolutionary remnants or genomic elements with no direct role in cell biology or disease[1][3][4]. No evidence supports functional or disease-related activity from SRSF8CP. In summary, SRSF8CP is a pseudogene and not a canonical molecular target for therapy or research, nor does it encode any actionable protein product[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine and arginine rich splicing factor 8C, pseudogene (SRSF8CP).